ArticlePLoS pathogens2026
Equine infectious anemia virus blocks interferon responses through Rev-mediated activation of the stress granule-PKR-eIF2α pathway.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type I interferons (IFNs) play a pivotal role in antiviral defence by inducing interferon-stimulated genes (ISGs) that target multiple stages of viral replication. Equine infectious anemia virus (EIAV) is an ancient lentivirus that establishes long-term asymptomatic infections in equids, suggesting its exceptional immune evasion capabilities. However, the mechanisms by which EIAV modulates IFN responses remain unclear. Here, we demonstrate that EIAV infection attenuates ISG expression at the post-transcriptional level. The viral Rev protein plays a central role by interacting with the stress granule (SG) nucleating protein Ras-GTPase-activating protein binding protein 1 (G3BP1) to induce SG formation. This triggers the phosphorylation of double-stranded RNA-dependent protein kinase (PKR) and eukaryotic initiation factor 2α (eIF2α), which then block the translation of ISGs. Knockdown of G3BP1 or inhibition of PKR activation restores ISGs expression and enhances the antiviral effect of IFN against EIAV. Furthermore, the dimerization and RNA-binding domains of Rev are essential for SG assembly and the subsequent inhibition of IFN responses. Collectively, our findings reveal that EIAV has evolved a unique strategy to evade IFN responses, where the Rev protein reprograms SGs into proviral platforms by suppressing the translation of ISGs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.